Advanced search
Publication Cover
Neuro-Ophthalmology Volume 45, 2021 - Issue 5
Submit an article Journal homepage
124
Views
7
CrossRef citations to date
0
Altmetric
Case Reports

A Case of Recurrent Painful Ophthalmoplegic Neuropathy Successfully Treated with Beta-blocker Eye Drop Instillation

Daisuke Takemotoa Department of Ophthalmology, Kanazawa University Graduate School of Medical Science, Kanazawa, JapanCorrespondence[email protected]
,
Shinji Ohkuboa Department of Ophthalmology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan;b Ohukubo Eye Clinic, Kanazawa, Japan
,
Sachiko Udagawaa Department of Ophthalmology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan
,
Mondo Kurodac Department of Pediatrics, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan
&
Kazuhisa Sugiyamaa Department of Ophthalmology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan
Pages 320-323 | Received 14 May 2020, Accepted 29 Jun 2020, Published online: 22 Jul 2020

References

  • Hansen SL, Borelli-Møller L, Strange P, Nielsen BM, Olesen J. Ophthalmoplegic migraine: diagnostic criteria, incidence of hospitalization and possible etiology. Acta Neurol Scand. 2009;81(1):54–60. doi:10.1111/j.1600-0404.1990.tb00931.x.
  • Gelfand AA, Gelfand JM, Prabakhar P, Goadsby PJ. Ophthalmoplegic “migraine” or recurrent ophthalmoplegic cranial neuropathy: new cases and a systematic review. J Child Neurol. 2012;27:759–766. doi:10.1177/0883073811426502.
  • Manzouri B, Sainani A, Plant G, Lee J, Sloper J. The aetiology and management of long-lasting sixth nerve palsy in ophthalmoplegic migraine. Cephalalgia. 2007;27:275–278.
  • McMillan HJ, Keene DL, Jacob P, Humphreys P. Ophthalmoplegic migraine: inflammatory neuropathy with secondary migraine? Can J Neurol Sci. 2007;34:349–355.
  • Gelfand AA, Gelfand JM, Prabakhar P, Goadsby PJ. Ophthalmoplegic “migraine” or recurrent ophthalmoplegic cranial neuropathy: new cases and a systematic review. J Child Neurol. 2012;27:759–766. doi:10.1177/0883073811426502.
  • Mark AS, Casselman J, Brown D, Sanchez J, Kolsky M, Larsen TC. Ophthalmoplegic migraine: reversible enhancement and thickening of the cisternal segment of the oculomotor nerve on contrast-enhanced MR images. AJNR Am J Neuroradiol. 1998;19:1887–1891.
  • Bharucha DX, Campbell TB, Valencia I, Hardison HH, Kothare SV. MRI findings in pediatric ophthalmoplegic migraine: a case report and literature review. Pediatr Neurol. 2007;37:59–63.
  • McMillan HJ, Keene DL, Jacob P, Humphreys P. Ophthalmoplegic migraine: inflammatory neuropathy with secondary migraine? Can J Neurol Sci. 2007;34:349–355.
  • Bek S, Genc G, Demirkaya S, Eroglu E, Odabasi Z. Ophthalmoplegic migraine. Neurologist. 2009;15:147–149.
  • Sakuma A, Shiraishi H, Shinmei Y, et al. Recurrent painful ophthalmoplegic neuropathy in a child: a case report. Neuro-ophthalmol Jpn. 2020;37:51–57
  • Crevits L, Verschelde H, Casselman J. Ophthalmoplegic migraine: an unresolved problem. Cephalalgia. 2006;26:1255–1259.
  • Verhagen WI, Prick MJ, van Dijk Azn R. Onset of ophthalmoplegic migraine with abducens palsy at middle age? Headache. 2003;43:798–800.
  • Pareja JA, Churruca J, de la Casa FB, de Silanes CL, Sánchez C, Barriga FJ. Ophthalmoplegic migraine. Two patients with an absolute response to indomethacin. Cephalalgia. 2010;30:757–760. doi:10.1111/j.1468-2982.2009.02003.x.
  • Zamproni LN, Ribeiro RT, Cardeal M. Treatment of recurrent painful ophthalmoplegic neuropathy: a case where pregabalin was successfully employed. Case Rep Neurol Med. 2019;9185603. doi:10.1155/2019/9185603.
  • Sugiyama N, Hamano S, Tanaka M, Mochizuki M, Nara T. MRI findings and effectiveness of cyproheptadine in two patients with ophthalmoplegic migraine. No To Hattatsu. 2002;34:533–537.
  • Smith SV, Schuster NM. Relapsing painful ophthalmoplegic neuropathy: no longer a “migraine,” but still a headache. Curr Pain Headache Rep. 2018;22:50. doi:10.1007/s11916-018-0705-5.
  • Ishikawa H, Yoshihara M, Mizuki K, Kashima Y. A pediatric case of ophthalmoplegic migraine with recurrent oculomotor nerve palsy. Jpn J Ophthalmol. 2000;104:179–182.
  • Notta A. Mémoire sur les lésions functionneles qui sont sous la dépendence des néuralgies. Arch gen med 5 me sér. 1854;4:1–29, 290–316.
  • Walsh FB, Hoyt WF. eds. Clinical Neuro-Ophthalmology. 3rd. Baltimore:Williams & Wilkins;1969 1674.
  • Lance JW, Zagami AS. Ophthalmoplegic migraine: a recurrent demyelinating neuropathy? Cephalalgia. 2001;21:84–89.
  • Carlow TJ. Oculomotor ophthalmoplegic migraine: is it really migraine? J Neuroophthalmol. 2002;22:215–221.
  • Olsson Y. Topographical differences in the vascular permeability of the peripheral nervous system. Acta Neuropathol. 1968;10:26–33.
  • Silberstein SD Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the quality standards subcommittee of the American academy of neurology. Neurology. 2000;55:754–762. doi: 10.1212/wnl.55.6.754.
  • Migliazzo CV, Hagan JCIII. Beta blocker eyedrops for treatment of acute migraine. Mo Med. 2014;111:283–288.
  • Cossack M, Nabrinsky E, Turner H, Abraham A, Gratton S. Timolol eyedrops in the treatment of acute migraine attacks: a randomized crossover study. JAMA Neurol. 2018;75:1024–1025. doi:10.1001/jamaneurol.2018.0970.
  • Urtti A, Rouhiainen H, Kaila T, Saano V. Controlled ocular timolol delivery: systemic absorption and intraocular pressure effects in humans. Pharm Res. 1994;11:1278–1282. doi:10.1023/a:1018938310628.
  • Korte J-M, Kaila T, Matti Saari K. Systemic bioavailability and cardiopulmonary effects of 0.5% timolol eyedrops. Graefes Arch Clin Exp Ophthalmol. 2002;240:430–435. doi:10.1007/s00417-002-0462-2.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.